InMode Ltd - Asset Resilience Ratio
InMode Ltd (INMD) has an Asset Resilience Ratio of 32.98% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check INMD PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how InMode Ltd's Asset Resilience Ratio has changed over time. See InMode Ltd (INMD) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down InMode Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INMD market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $252.79 Million | 32.98% |
| Total Liquid Assets | $252.79 Million | 32.98% |
Asset Resilience Insights
- Very High Liquidity: InMode Ltd maintains exceptional liquid asset reserves at 32.98% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
InMode Ltd Industry Peers by Asset Resilience Ratio
Compare InMode Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for InMode Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for InMode Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 32.98% | $252.79 Million | $766.43 Million | -23.17pp |
| 2024-12-31 | 56.15% | $441.14 Million | $785.67 Million | -13.03pp |
| 2023-12-31 | 69.18% | $597.19 Million | $863.29 Million | -0.63pp |
| 2022-12-31 | 69.81% | $449.84 Million | $644.41 Million | -2.87pp |
| 2021-12-31 | 72.67% | $347.78 Million | $478.54 Million | +7.89pp |
| 2020-12-31 | 64.78% | $191.60 Million | $295.76 Million | -3.28pp |
| 2019-12-31 | 68.06% | $148.63 Million | $218.38 Million | +22.94pp |
| 2018-12-31 | 45.13% | $36.58 Million | $81.06 Million | +26.24pp |
| 2017-12-31 | 18.88% | $7.45 Million | $39.44 Million | +9.25pp |
| 2016-12-31 | 9.63% | $1.59 Million | $16.49 Million | -- |
About InMode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simulta… Read more